HK1014552A1 - Soluble cri derivatives - Google Patents

Soluble cri derivatives

Info

Publication number
HK1014552A1
HK1014552A1 HK98115862A HK98115862A HK1014552A1 HK 1014552 A1 HK1014552 A1 HK 1014552A1 HK 98115862 A HK98115862 A HK 98115862A HK 98115862 A HK98115862 A HK 98115862A HK 1014552 A1 HK1014552 A1 HK 1014552A1
Authority
HK
Hong Kong
Prior art keywords
derivatives
cri
soluble
soluble cri
cri derivatives
Prior art date
Application number
HK98115862A
Other languages
English (en)
Inventor
Richard Anthony Godwin Smith
Ian Dodd
Anne Mary Freeman
Danuta Ewa Irena Mossakowska
Original Assignee
Adprotech Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929213376A external-priority patent/GB9213376D0/en
Priority claimed from GB939304057A external-priority patent/GB9304057D0/en
Application filed by Adprotech Plc filed Critical Adprotech Plc
Publication of HK1014552A1 publication Critical patent/HK1014552A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
HK98115862A 1992-06-24 1998-12-28 Soluble cri derivatives HK1014552A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929213376A GB9213376D0 (en) 1992-06-24 1992-06-24 Novel compounds
GB939304057A GB9304057D0 (en) 1993-03-01 1993-03-01 Novel compounds
PCT/GB1993/001282 WO1994000571A1 (en) 1992-06-24 1993-06-16 Soluble cr1 derivatives

Publications (1)

Publication Number Publication Date
HK1014552A1 true HK1014552A1 (en) 1999-09-30

Family

ID=26301119

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98115862A HK1014552A1 (en) 1992-06-24 1998-12-28 Soluble cri derivatives

Country Status (6)

Country Link
US (2) US5833989A (ja)
EP (1) EP0649468B1 (ja)
JP (1) JP3939747B2 (ja)
DE (1) DE69328098T2 (ja)
HK (1) HK1014552A1 (ja)
WO (1) WO1994000571A1 (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3689422B2 (ja) * 1993-02-12 2005-08-31 アーヴァント イミュノセラピューティクス インコーポレイテッド ｓＣＲ１およびその他の補体阻害蛋白の肺内投与
US6074642A (en) * 1994-05-02 2000-06-13 Alexion Pharmaceuticals, Inc. Use of antibodies specific to human complement component C5 for the treatment of glomerulonephritis
GB9604518D0 (en) * 1996-03-02 1996-05-01 Smithkline Beecham Plc Novel compounds
GB9614871D0 (en) 1996-07-15 1996-09-04 Smithkline Beecham Plc Compounds
GB9624731D0 (en) * 1996-11-28 1997-01-15 Univ Leicester Complement inhibitor
GB9704519D0 (en) 1997-03-05 1997-04-23 Smithkline Beecham Plc Compounds
WO1998040743A1 (en) * 1997-03-10 1998-09-17 Beth Israel Deaconess Medical Center Immune complexes and methods of detection and treatment thereof
GB9706950D0 (en) * 1997-04-05 1997-05-21 Chernajovsky Yuti Immune modulation by polypeptides related to CR1
GB9905503D0 (en) * 1999-03-10 1999-05-05 Adprotech Plc Novel compound formulations and methods of delivery
EP1186299A1 (en) * 2000-09-12 2002-03-13 Universitair Medisch Centrum Utrecht The diagnosis, prevention, and/or succesful treatment of atherosclerosis, infectious diseases, and disturbances in the immune system
US9415102B2 (en) 2002-09-06 2016-08-16 Alexion Pharmaceuticals, Inc. High concentration formulations of anti-C5 antibodies
US20050271660A1 (en) 2002-09-06 2005-12-08 Alexion Pharmaceuticals, Inc. Nebulization of monoclonal antibodies for treating pulmonary diseases
CA2496834C (en) * 2002-09-06 2014-03-18 Alexion Pharmaceuticals, Inc. Method of treatment of asthma using antibodies to complement component c5
WO2005069726A2 (en) * 2004-01-21 2005-08-04 Case Western Reserve University Hybrid and chimeric polypeptides that regulate activation of complement
US7951529B2 (en) * 2004-09-17 2011-05-31 The Johns Hopkins University Biomarkers for breast cancer
US7897561B2 (en) 2005-06-06 2011-03-01 Girish J. Kotwal Methods for treatment or prophylaxis of atherosclerosis and reperfusion injury
DE102007010843B3 (de) * 2007-03-04 2008-09-11 Cytocentrics Ag Verfahren und Vorrichtung
GB201800620D0 (en) 2018-01-15 2018-02-28 Univ Manchester C3b Binding Polypeptide
US20210238238A1 (en) 2018-05-16 2021-08-05 Csl Limited Soluble complement receptor type i variants and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212071A (en) * 1988-04-01 1993-05-18 The Johns Hopkins University Nucleic acids encoding a human C3b/C4b receptor (CR1)
IL89790A (en) * 1988-04-01 2002-05-23 Johns Hopking University Sequences of nucleic acids encoding and cells producing CR1 protein and methods for its production and purification

Also Published As

Publication number Publication date
WO1994000571A1 (en) 1994-01-06
EP0649468A1 (en) 1995-04-26
DE69328098T2 (de) 2000-08-24
US5859223A (en) 1999-01-12
JP3939747B2 (ja) 2007-07-04
DE69328098D1 (de) 2000-04-20
JPH07508516A (ja) 1995-09-21
US5833989A (en) 1998-11-10
EP0649468B1 (en) 2000-03-15

Similar Documents

Publication Publication Date Title
PL307812A1 (en) Substituted thiazolydinone derivatives
HU9203384D0 (en) Water-soluble camptotecine derivatives
GB9211706D0 (en) Peptidyl derivatives
HK1014552A1 (en) Soluble cri derivatives
GB9211707D0 (en) Peptidyl derivatives
HK1011350A1 (en) Arylamide derivatives
GB9305306D0 (en) Pyrrolo-pyridazione derivatives
HU9301955D0 (en) Benzophenone-hydrazone derivatives
GB9320077D0 (en) Quinazoline derivatives
ZA931876B (en) 2-Oxoquinoline derivatives
ZA932639B (en) Propenoyl-imidazole derivatives
HU9301616D0 (en) New thio-semicarbazone derivatives
ZA938350B (en) Antineoplastic heteronaphthoquinones
GB2270913B (en) Chlordifluoromethoxyphenyl derivatives
GB2271564B (en) Thioalkylthio carbacephalosporin derivatives
ZA931516B (en) Substituted phenylquinazoline derivatives
EP0565961A3 (en) Ethyl-triazolyl derivatives
GB9223244D0 (en) Phenylpyrazine derivatives
HU9302058D0 (en) Thia-diazinone derivatives
GB9200826D0 (en) Peptidyl derivatives
HU9301696D0 (en) Pyrimidofuroxane derivatives
HU9202008D0 (en) New 4-methyl-2-imidazolinone derivatives
GB9202934D0 (en) Imidazopiperidine derivatives
GB9202355D0 (en) Benzodioxanylimidazoline derivatives
ZA932575B (en) Ethyl-triazolyl derivatives

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20100616